Target intelligence / Profile preview

Hypoxia-inducible factor 2 alpha promoter G-quadruplex (HIF-2a G4)

Target
HIF-2a G4
Molecular classification
G-quadruplex, Nucleic acid structure, Transcription regulator
01

Overview

The Hypoxia-inducible factor 2 alpha (HIF-2 alpha) promoter G-quadruplex is a non-canonical, four-stranded nucleic acid structure located within the guanine-rich regulatory region of the EPAS1 gene. This structural motif acts as a molecular switch that modulates the transcription of HIF-2 alpha, a transcription factor essential for the cellular response to low-oxygen environments. In normal physiology, HIF-2 alpha regulates genes involved in angiogenesis, red blood cell production, and metabolic adaptation; however, in many cancers, such as clear cell renal cell carcinoma, it is constitutively overexpressed and drives tumor progression. Small-molecule ligands, such as the experimental compound CL67, are designed to bind and stabilize this G-quadruplex structure, creating a physical barrier that prevents the transcriptional machinery from accessing the gene. This stabilization leads to the downregulation of EPAS1 mRNA and a subsequent decrease in HIF-2 alpha protein levels, offering a potential strategy to inhibit tumor growth and vascularization. Therapeutic challenges for this target include achieving high selectivity for the EPAS1 G-quadruplex over other genomic structures and managing potential systemic toxicity from the broad inhibition of hypoxia-responsive pathways.

Other names
EPAS1 G-quadruplexHIF-2 alpha G4EPAS1 promoter G-quadruplexHypoxia-inducible factor 2-alpha gene G-quadruplexEndothelial PAS domain-containing protein 1 promoter G-quadruplex
02

Mechanism of action

Ligand-mediated stabilization of the G-quadruplex structure within the EPAS1 promoter, which sterically inhibits the binding of transcription factors or the progression of RNA polymerase, thereby reducing the transcription and expression of the HIF-2 alpha protein.

03

Biological functions

Transcriptional regulationResponse to hypoxiaCellular adaptation to low oxygenAngiogenesisErythropoiesis
04

Disease associations

CancerRenal cell carcinomaSolid tumorParagangliomaPheochromocytomaErythrocytosis
05

Safety considerations

Off-target binding to other genomic G-quadruplex sitesPotential systemic toxicity of small-molecule G4 stabilizersImpairment of physiological hypoxic responses in healthy tissuesPotential for genomic instability
06

Interacting drugs

CL67
07

Biomarkers

EPAS1 mRNA levelsHIF-2 alpha protein levelsVEGF expression levelsErythropoietin (EPO) levels

Beyond the preview

Go deeper on Hypoxia-inducible factor 2 alpha promoter G-quadruplex (HIF-2a G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypoxia-inducible factor 2 alpha promoter G-quadruplex (HIF-2a G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call